1. The Director shall create a Pharmacy and Therapeutics Committee within the Department. The Committee must consist of at least 5 members and not more than 11 members appointed by the Governor based on recommendations from the Director.
2. The Governor shall appoint to the Committee health care professionals who have knowledge and expertise in one or more of the following:
(a) The clinically appropriate prescribing of outpatient prescription drugs that are covered by Medicaid;
(b) The clinically appropriate dispensing and monitoring of outpatient prescription drugs that are covered by Medicaid;
(c) The review of, evaluation of and intervention in the use of prescription drugs; and
(d) Medical quality assurance.
3. At least one-third of the members of the Committee must be active physicians licensed to practice medicine in this State, at least one of whom must be an active psychiatrist licensed to practice medicine in this State. At least one-third of the members of the Committee must be either active pharmacists registered in this State or persons in this State with doctoral degrees in pharmacy.
4. A person must not be appointed to the Committee if the person is employed by, compensated by in any manner, has a financial interest in, or is otherwise affiliated with a business or corporation that manufactures prescription drugs.
(Added to NRS by 2003, 1318; A 2015, 304)